BMS claims pharma’s most powerful AI supercomputer. How it stacks up to Lilly’s and Roche’s.

Summary

Bristol Myers Squibb announced deployment of an NVIDIA DGX SuperPOD supercomputing platform, claiming it as the most powerful and energy-efficient single-owned NVIDIA infrastructure in life sciences, positioning itself competitively against Eli Lilly and Roche.